» Articles » PMID: 18164058

Inhibitory Control and Emotional Stress Regulation: Neuroimaging Evidence for Frontal-limbic Dysfunction in Psycho-stimulant Addiction

Overview
Date 2008 Jan 1
PMID 18164058
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

This review focuses on neuroimaging studies that examined stress processing and regulation and cognitive inhibitory control in patients with psycho-stimulant addiction. We provide an overview of these studies, summarizing converging evidence and discrepancies as they occur in the literature. We also adopt an analytic perspective and dissect these psychological processes into their sub-components, to identify the neural pathways specific to each component process and those that are more specifically involved in psycho-stimulant addiction. To this aim we refer frequently to studies conducted in healthy individuals. Despite the separate treatment of stress/affect regulation, stress-related craving or compulsive drug seeking, and inhibitory control, neural underpinnings of these processes overlap significantly. In particular, the ventromedial prefrontal regions including the anterior cingulate cortex, amygdala and the striatum are implicated in psychostimulant dependence. Our overarching thesis is that prefrontal activity ensures intact emotional stress regulation and inhibitory control. Altered prefrontal activity along with heightened striatal responses to addicted drug and drug-related salient stimuli perpetuates habitual drug seeking. Further studies that examine the functional relationships of these neural systems will likely provide the key to understanding the mechanisms underlying compulsive drug use behaviors in psycho-stimulant dependence.

Citing Articles

Resting state EEG delta-beta amplitude-amplitude coupling: a neural predictor of cortisol response under stress.

Wang X, Lin L, Zhan L, Sun X, Huang Z, Zhang L Cogn Neurodyn. 2024; 18(6):3995-4007.

PMID: 39712085 PMC: 11655767. DOI: 10.1007/s11571-024-10174-1.


Stress and substance use disorders: risk, relapse, and treatment outcomes.

Sinha R J Clin Invest. 2024; 134(16).

PMID: 39145454 PMC: 11324296. DOI: 10.1172/JCI172883.


Neurobiological mechanisms and related clinical treatment of addiction: a review.

Fang Y, Sun Y, Liu Y, Liu T, Hao W, Liao Y Psychoradiology. 2024; 2(4):180-189.

PMID: 38665277 PMC: 10917179. DOI: 10.1093/psyrad/kkac021.


Examining the role of dopamine in methylphenidate's effects on resting brain function.

Tomasi D, Manza P, Yan W, Shokri-Kojori E, Demiral S, Yonga M Proc Natl Acad Sci U S A. 2023; 120(52):e2314596120.

PMID: 38109535 PMC: 10756194. DOI: 10.1073/pnas.2314596120.


Neurochemical Effects of Methylphenidate and Modafinil in Ameliorating Stress-Induced Cognitive Deficits.

Alam N, Choudhary K ACS Pharmacol Transl Sci. 2023; 6(10):1357-1372.

PMID: 37854618 PMC: 10580386. DOI: 10.1021/acsptsci.3c00077.


References
1.
Grigson P, Twining R . Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards. Behav Neurosci. 2002; 116(2):321-33. View

2.
Cox W, Fadardi J, Pothos E . The addiction-stroop test: Theoretical considerations and procedural recommendations. Psychol Bull. 2006; 132(3):443-76. DOI: 10.1037/0033-2909.132.3.443. View

3.
Konishi S, Nakajima K, Uchida I, Sekihara K, Miyashita Y . No-go dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. Eur J Neurosci. 1998; 10(3):1209-13. DOI: 10.1046/j.1460-9568.1998.00167.x. View

4.
Robinson T, Berridge K . Addiction. Annu Rev Psychol. 2002; 54:25-53. DOI: 10.1146/annurev.psych.54.101601.145237. View

5.
Lanius R, Williamson P, Densmore M, Boksman K, Gupta M, Neufeld R . Neural correlates of traumatic memories in posttraumatic stress disorder: a functional MRI investigation. Am J Psychiatry. 2001; 158(11):1920-2. DOI: 10.1176/appi.ajp.158.11.1920. View